XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

209 hedge funds and large institutions have $2.99B invested in Xenon Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 66 increasing their positions, 69 reducing their positions, and 20 closing their positions.

Holders
209
Holders Change
+7
Holders Change %
+3.47%
% of All Funds
2.78%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.17%
New
29
Increased
66
Reduced
69
Closed
20
Calls
$4.36M
Puts
$82K
Net Calls
+$4.28M
Net Calls Change
+$636K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$295M
2
Westfield Capital Management
2
Westfield Capital Management
Massachusetts
$45.4M
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$53.2M
4
SC
4
Stempoint Capital
New York
$14.7M
5
FTM
5
First Turn Management
California
$26.9M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$12.8M
2
Capital World Investors
2
Capital World Investors
California
$89.9M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$0
4
APM
4
Avidity Partners Management
Texas
$18.6M
5
Marshall Wace
5
Marshall Wace
United Kingdom
$35.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Investments
51
Two Sigma Investments
New York
$10.7M +$1.17M +29,773 +12%
Dimensional Fund Advisors
52
Dimensional Fund Advisors
Texas
$10.2M -$1.56M -39,895 -13%
GPP
53
Great Point Partners
Connecticut
$9.61M +$9.61M +245,272 New
AG
54
Algert Global
California
$9.46M +$854K +21,772 +10%
Assenagon Asset Management
55
Assenagon Asset Management
Luxembourg
$9.35M +$1.03M +26,235 +12%
Walleye Capital
56
Walleye Capital
New York
$8.7M +$4.59M +117,022 +111%
Russell Investments Group
57
Russell Investments Group
United Kingdom
$8.38M -$389K -9,918 -4%
Invesco
58
Invesco
Georgia
$8.21M -$246K -6,268 -3%
DnB Asset Management
59
DnB Asset Management
Norway
$7.97M +$495K +12,620 +7%
MB
60
MPM BioImpact
Massachusetts
$7.73M +$1.23M +31,412 +19%
Lord, Abbett & Co
61
Lord, Abbett & Co
New Jersey
$7.64M +$823K +20,986 +12%
PHP
62
Parkman Healthcare Partners
Connecticut
$7.57M +$52.8K +1,346 +0.7%
UBS AM
63
UBS AM
Illinois
$7.52M +$1.14M +29,169 +18%
Axa
64
Axa
France
$7.36M -$11.5K -294 -0.2%
Balyasny Asset Management
65
Balyasny Asset Management
Illinois
$7.24M +$3.93M +100,382 +119%
GIM
66
Granahan Investment Management
Massachusetts
$7.15M -$727K -18,544 -9%
Schroder Investment Management Group
67
Schroder Investment Management Group
United Kingdom
$6.81M – – –
DTC
68
Deep Track Capital
Connecticut
$6.63M +$6.63M +169,132 New
EP
69
Eversept Partners
New York
$6.1M +$6.1M +155,540 New
BM
70
Bridger Management
New York
$5.75M – – –
New York State Common Retirement Fund
71
New York State Common Retirement Fund
New York
$5.2M – – –
ABG
72
Ally Bridge Group
New York
$5.07M -$3.23M -82,500 -39%
Swiss National Bank
73
Swiss National Bank
Switzerland
$4.96M +$51K +1,300 +1%
PHS
74
PFM Health Sciences
California
$4.59M -$2.46M -62,880 -35%
Bank of America
75
Bank of America
North Carolina
$4.19M -$806K -20,550 -16%
1 2
3
4 5